Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Queensland Health
Colorcon
Chinese Patent Office
Harvard Business School

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,827,329

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,827,329
Title:Compounds and compositions for immunotherapy
Abstract: Provided are compounds for targeted immunotherapy. The compounds are useful in the treatment of diseases such as cancer. Also provided are compositions comprising the compounds.
Inventor(s): Li; Lixin (Beijing, CN)
Assignee: BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY)
Application Number:15/110,685
Patent Claims:see list of patent claims

Details for Patent 9,827,329

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX Orphan search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Sign Up BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 002 2006-09-27 ➤ Sign Up BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Covington
Federal Trade Commission
Johnson and Johnson
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.